BDBM286319 N-(1H-benzo[d]imidazol-2-yl)-3-((3-(5-((dimethylamino)methyl)pyridin-3-yl)-6-oxopyridazin-1(6H)-yl)methyl)benzamide::US9567320, Example 14

SMILES CN(C)Cc1cncc(c1)-c1ccc(=O)n(Cc2cccc(c2)C(=O)Nc2nc3ccccc3[nH]2)n1

InChI Key InChIKey=QATZADCKICVGJG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 286319   

TargetInterleukin-1 receptor-associated kinase 4(Human)
Merck Patent

US Patent
LigandPNGBDBM286319(N-(1H-benzo[d]imidazol-2-yl)-3-((3-(5-((dimethylam...)
Affinity DataIC50: 3.00E+3nMAssay Description:IRAK4 hydrolyses ATP, autophosphorylates and phosphorylates a Serine/Threonine generic peptidic substrate (STK: 61ST1BLC from CisBio International ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
Go to US Patent